Sigma Healthcare (Sigma Healthcare) Debt-to-Asset : 0.10 (As of Jan. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Sigma Healthcare Debt-to-Asset?

Sigma Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $6 Mil. Sigma Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $84 Mil. Sigma Healthcare's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jan. 2024 was $914 Mil. Sigma Healthcare's debt to asset for the quarter that ended in Jan. 2024 was 0.10.

Sigma Healthcare Debt-to-Asset Historical Data

The historical data trend for Sigma Healthcare's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sigma Healthcare Debt-to-Asset Chart

Sigma Healthcare Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Debt-to-Asset

Get a 7-Day Free Trial

0.25

0.18

0.26

0.19

0.10

Sigma Healthcare Semi-Annual Data
	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jan24
Debt-to-Asset	Get a 7-Day Free Trial															0.26	0.21	0.19	0.22	0.10

Competitive Comparison of Sigma Healthcare's Debt-to-Asset

For the Medical Distribution subindustry, Sigma Healthcare's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sigma Healthcare's Debt-to-Asset Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Sigma Healthcare's Debt-to-Asset falls into.

Sigma Healthcare Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Sigma Healthcare's Debt-to-Asset for the fiscal year that ended in Jan. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(6.496	+	84.169)	/	914.341
	=	0.10

Sigma Healthcare's Debt-to-Asset for the quarter that ended in Jan. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(6.496	+	84.169)	/	914.341
	=	0.10

Sigma Healthcare (OTCPK:SIGGF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Sigma Healthcare Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Sigma Healthcare's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Sigma Healthcare (Sigma Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sigma Healthcare Ltd (OTCPK:SIGGF) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

S5YA:Germany SIG:Australia

Address

2125 Dandenong Road, Level 6, Clayton, Melbourne, VIC, AUS, 3168

Website

https://www.sigmahealthcare.com.au

Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.